Aparna Nemlekar
Posts by Aparna Nemlekar
Freedom to Operate and the Interplay of Patent and Regulatory Exclusivity for Life Sciences
While part one of this two-part series on intellectual property (IP) due diligence focused on a life science company’s own IP portfolio, part two will address …
IP Due Diligence in the Life Sciences: Key Considerations for 2019
The success of a life science product, and thereby the company, rests heavily upon a combination of patent protection, regulatory exclusivity and product life cycle management. A …